Globavend Holdings Limited (NASDAQ: GVH) today announced that all outstanding Series A Warrants issued in connection with its June 2025 public offering have expired, leaving the company with no outstanding warrants. The company stated that this move simplifies its capital structure, eliminates a potential source of future shareholder dilution, and supports its focus on disciplined capital management and long-term shareholder value creation.
The expiration marks a strategic step for Globavend as it continues to execute its dual-business strategy. The company is expanding its AI-powered digital entertainment business while strengthening its cross-border e-commerce logistics operations. According to the announcement, Globavend highlighted the commercial launch of its proprietary Imaginary AI production platform and its first fully AI-produced original micro-drama as milestones that support its long-term growth trajectory.
Further details are available in the full press release at https://nnw.fm/74QYv.
Globavend Holdings Limited (NASDAQ: GVH) is an emerging e-commerce logistics provider and AI-powered digital entertainment company. As a logistics provider, the company offers integrated cross-border logistics solutions across Hong Kong, Australia, New Zealand and mainland China. As a digital entertainment company, the company develops generative AI-assisted cinematic production workflows, multimodal content generation capabilities and multilingual digital entertainment distribution solutions through its proprietary AI technologies. It operates Loomi: Short Drama, a mobile streaming platform offering professionally produced multilingual micro dramas, and Imaginary, its proprietary AI-powered cinematic production platform, providing end-to-end AI-assisted content creation capabilities. By combining AI-powered production technologies with proprietary distribution capabilities, Globavend is building an integrated digital entertainment ecosystem while continuing to expand its established cross-border logistics business.
For more information about Globavend, visit https://globavend.com/.
